We recently demonstrated that reduced Mdm4 expression or its genetic ablation promoted lung fibrosis resolution by activating the Mdm4-p53 pathway in aged mice, highlighting the potential of MDM4 as a therapeutic target for the treatment of lung fibrosis 12. The gene discussed is TP53; the disease is pulmonary fibrosis.